Market By Application, Route Of Administration, End-user And Country | Forecast 2019-2028
Triton Market Research’s report on the clinical nutrition market in the Asia-Pacific region interprets that it is set to expand at a CAGR of 5.85% over the projected years (2019-2028).
Report scope can be customized per your requirements. Request For Customization
The countries studied in the Asia-Pacific clinical nutrition market are:
• South Korea
• China
• ASEAN countries
• Japan
• India
• Australia & New Zealand
• Rest of APAC
The clinical nutrition market in the Asia-Pacific region is witnessing considerable growth due to the expanding geriatric population in the region and the rising incidence of lifestyle-related disorders. Besides, the advanced health standards, coupled with the rising healthcare expenditure, are also contributing to the market growth. Japan is one of the lucrative markets for geriatric clinical nutrition owing to the large aging population group. It is estimated that, by 2030, every third person in the country will be over 65 years old. The geriatric population is likely to create an increased demand for nutritional supplements, thereby boosting the clinical nutrition market growth. The people in Japan are considered to be highly health-conscious, focusing largely on consuming a nutritionally balanced diet. All these factors indicate an increased growth in the clinical nutrition market in Japan.
China is among the largest clinical nutrition markets in the region. It is expected to grow further over the forecast period, owing to the COVID-19 pandemic. There is an increased public awareness regarding clinical nutrition, which is boosting the overall market growth in China. The young consumers in the country are the major drivers for the market. With their entirely different shopping behavior, which is highly influenced by the urbanization and knowledge about health benefits, the clinical nutrition market is expected to experience substantial demand.
Meiji Holdings Co Ltd is a company involved in the manufacturing and sales of food & medicines. The company has two major business operations, namely food and pharmaceuticals. The first segment includes the production & marketing of products like cheese and butter, among others, and pharmaceuticals include manufacturing and sales of agricultural chemicals, ethical pharmaceuticals and animal drugs. Meiji Mei Balance is an enteral formula offered by the company that is given to the patients suffering from low appetite by providing well-balanced nutrients. The company is headquartered in Chuo-Ku, Japan.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. ASIA-PACIFIC CLINICAL NUTRITION MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. KEY INSIGHTS
2.7. MARKET DRIVERS
2.7.1. INCREASING NUMBER OF PEOPLE SUFFERING FROM CHRONIC HEALTH DISEASES
2.7.2. SURGING NUMBER OF MALNUTRITION VICTIMS
2.8. MARKET RESTRAINTS
2.8.1. DIFFICULTIES RELATED TO ENTERAL FEEDING
2.8.2. LACK OF AWARENESS REGARDING CLINICAL NUTRITION
2.9. MARKET OPPORTUNITIES
2.9.1. GROWING AGING POPULATION
2.9.2. RISING USAGE OF CLINICAL NUTRITION IN DEVELOPING COUNTRIES
2.10. MARKET CHALLENGES
2.10.1. STRINGENT REGULATORY FRAMEWORK
2.10.2. FALSE PERCEPTIONS ASSOCIATED WITH MALNUTRITION
3. CLINICAL NUTRITION MARKET OUTLOOK - BY APPLICATION
3.1. CANCER
3.2. NEUROLOGICAL DISEASES
3.3. GASTROINTESTINAL DISORDERS
3.4. METABOLIC DISORDERS
3.5. OTHER APPLICATIONS
4. CLINICAL NUTRITION MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. ENTERAL
4.3. PARENTERAL
5. CLINICAL NUTRITION MARKET OUTLOOK - BY END-USER
5.1. PEDIATRIC
5.2. GERIATRIC
5.3. ADULTS
6. CLINICAL NUTRITION MARKET – ASIA-PACIFIC
6.1. JAPAN
6.2. CHINA
6.3. INDIA
6.4. AUSTRALIA & NEW ZEALAND
6.5. SOUTH KOREA
6.6. ASEAN COUNTRIES
6.7. REST OF ASIA-PACIFIC
7. COMPANY PROFILES
7.1. NESTLE HEALTH SCIENCE
7.2. BASF SE
7.3. AVADEL PHARMACEUTICALS
7.4. MEIJI HOLDINGS CO LTD
7.5. BAXTER INTERNATIONAL INC
7.6. RECKITT BENCKISER GROUP PLC
7.7. B BRAUN
7.8. SANOFI SA
7.9. AMERICAN REGENT INC
7.10. OTSUKA HOLDINGS CO LTD
7.11. ABBOTT LABORATORIES
7.12. SICHUAN KELUN PHARMACEUTICAL CO LTD
7.13. LONZA INC
7.14. DANONE
7.15. GRIFOLS SA
7.16. EXELA PHARMA SCIENCES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 ASIA-PACIFIC CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 4 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 5 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 6 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1 ASIA-PACIFIC CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 2 DIFFICULTIES ASSOCIATED WITH ENTERAL FEEDING
FIGURE 3 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
FIGURE 4 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
FIGURE 5 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 6 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 7 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 8 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
FIGURE 9 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 10 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 11 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 12 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 13 ASIA-PACIFIC CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
FIGURE 14 JAPAN CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 15 CHINA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 16 INDIA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 17 AUSTRALIA & NEW ZEALAND CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 18 SOUTH KOREA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 19 ASEAN COUNTRIES CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 20 REST OF ASIA-PACIFIC CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)